Table 2.
Comparison of different clinical features and complications (a Median (IQR);b n [%]).
MetS patients (n = 74) | Non-MetS patients (n = 83) | p-value | |
---|---|---|---|
ICU length of staya | 10 [[6], [8], [9], [10], [11], [12], [13], [14], [23]] | 8 [[5], [6], [8], [9], [10], [11], [12], [13], [23]] | 0.009 |
Hospital length of staya | 18 [[9], [10], [11], [12], [13], [14], [16], [17], [24]] | 11 [[9], [10], [11], [12], [13], [14], [16]] | 0.02 |
Invasive mechanical ventilationb | 57 [77.0%] | 39 [46.9%] | 0.0001 |
SOFA score (upon admission to ICU)a | 4 [[2], [3], [4], [5], [6], [8], [23]] | 3 [[2], [3], [4], [5], [6], [8]] | 0.01 |
Complicationsb | |||
Acute Respiratory Distress Syndrome (ARDS) | 60 [81.1%] | 72 [86.7%] | 0.33 |
Respiratory failure | 58 [78.4%] | 44 [53.0%] | 0.0008 |
Pulmonary embolism | 2 [2.7%] | 0 [0%] | 0.22 |
Secondary infection | 13 [17.6%] | 15 [18.1%] | 0.93 |
Septic shock | 3 [4.1%] | 3 [3.6%] | 0.88 |
Acute kidney failure | 39 [52.7%] | 33 [39.7%] | 0.10 |
Acute liver failure | 41 [55.4%] | 37 [44.6%] | 0.17 |
Acute cardiac injury | 11 [14.9%] | 6 [7.2%] | 0.12 |
Myocardial infarction | 4 [5.4%] | 2 [2.4%] | 0.32 |
Coagulopathy | 23 [31.1%] | 16 [19.3%] | 0.087 |
Hyperproteinemia | 7 [9.5%] | 13 [15.7%] | 0.24 |
Acidosis | 45 [60.8%] | 51 [61.4%] | 0.93 |
Pressure Ulcer | 10[13.5%] | 3 [3.6%] | 0.02 |